citric acid, anhydrous has been researched along with Anodontia in 1 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Anodontia: Congenital absence of the teeth; it may involve all (total anodontia) or only some of the teeth (partial anodontia, hypodontia), and both the deciduous and the permanent dentition, or only teeth of the permanent dentition. (Dorland, 27th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hardies, K | 1 |
de Kovel, CG | 1 |
Weckhuysen, S | 1 |
Asselbergh, B | 1 |
Geuens, T | 1 |
Deconinck, T | 1 |
Azmi, A | 1 |
May, P | 1 |
Brilstra, E | 1 |
Becker, F | 1 |
Barisic, N | 1 |
Craiu, D | 1 |
Braun, KP | 1 |
Lal, D | 1 |
Thiele, H | 1 |
Schubert, J | 1 |
Weber, Y | 1 |
van 't Slot, R | 1 |
Nürnberg, P | 1 |
Balling, R | 1 |
Timmerman, V | 1 |
Lerche, H | 1 |
Maudsley, S | 1 |
Helbig, I | 1 |
Suls, A | 1 |
Koeleman, BP | 1 |
De Jonghe, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
SLC13A5 Deficiency: A Prospective Natural History Study - United States Only[NCT06144957] | 17 participants (Anticipated) | Observational | 2021-12-01 | Recruiting | |||
SLC13A5 Deficiency: A Prospective Natural History Study - Remote Only (International)[NCT04681781] | 20 participants (Anticipated) | Observational | 2021-03-01 | Enrolling by invitation | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for citric acid, anhydrous and Anodontia
Article | Year |
---|---|
Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia.
Topics: Adolescent; Anodontia; Brain Diseases; Child; Citric Acid; Developmental Disabilities; Epilepsy; Fem | 2015 |
Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia.
Topics: Adolescent; Anodontia; Brain Diseases; Child; Citric Acid; Developmental Disabilities; Epilepsy; Fem | 2015 |
Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia.
Topics: Adolescent; Anodontia; Brain Diseases; Child; Citric Acid; Developmental Disabilities; Epilepsy; Fem | 2015 |
Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia.
Topics: Adolescent; Anodontia; Brain Diseases; Child; Citric Acid; Developmental Disabilities; Epilepsy; Fem | 2015 |